Brands Available Details



Name: Ocrelizumb

View Drug Forms

Indications & Dose:

Multiple sclerosis (specialist use only)


BY INTRAVENOUS INFUSION


Adult: Initially 300 mg, then 300 mg after 2 weeks maintenance 600 mg every 6 months, the first maintenance dose should be given 6 months after the first initial dose a minimum interval of 5 months should be maintained between each maintenance dose, for dose interruption, adjustment of infusion rate or discontinuation of treatment due to infusion-related reactions or side-effects—consult product literature


CONTRA-INDICATIONS Active infection . active malignancies . severely immunocompromised patients

Contraindications:

-

Cautions:

Complete required vaccinations at least 6 weeks before treatment initiation . hepatitis B reactivation

Precautions:

-

Interaction:

-

Warnings:

-

Adverse Effects:

-

Lactations:

-

Special Precautions:

-

Counselling:

-

Side Effects Or Adverse Reactions:

-

Patient And Carer Advice:

-